TrialThe oncologist2023

Nab-paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study.

Yin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.